mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.7 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.7 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |